The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity
2021 · Signal Transduction and Targeted Therapy · 39 citations
https://doi.org/10.1038/s41392-021-00525-3
L
Leiqiong Gao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
36
Papers
1.5K
Citations
15
h-index
16
i10-index
Leiqiong Gao is an academic researcher from Children's Hospital of Chongqing Medical University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & Respiratory viral infections research & Reproductive tract infections research. The author has an h-index of 15, co-authored 31 publications.
Papers by this author
worksA potent human monoclonal antibody with pan-neutralizing activities directly dislocates S trimer of SARS-CoV-2 through binding both up and down forms of RBD
2022 · Signal Transduction and Targeted Therapy · 25 citations
https://doi.org/10.1038/s41392-022-00954-8
Quantifying promoter activity during the developmental cycle of Chlamydia trachomatis
2016 · Scientific Reports · 8 citations
https://doi.org/10.1038/srep27244
Club cell 10-kDa protein (CC10) inhibits cPLA2/COX2 pathway to alleviate RSV-induced airway inflammation and AHR
2020 · International Immunopharmacology · 4 citations
https://doi.org/10.1016/j.intimp.2020.106327
p53 suppresses the inflammatory response following respiratory syncytial virus infection by inhibiting TLR2
2024 · Virology · 4 citations
https://doi.org/10.1016/j.virol.2024.110018
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat